Skip to main content
An official website of the United States government
Español
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

carboxypeptidase-G2

(kar-BOK-see-PEP-tih-days …)
A drug used to treat toxic levels of the anticancer drug methotrexate in the blood of adults and children with kidney problems. Carboxypeptidase-G2 is a bacterial enzyme that helps break down and remove methotrexate from the body. It may also help certain drugs kill cancer cells. Carboxypeptidase-G2 is a type of chemoprotective agent and a type of prodrug activator. Also called glucarpidase and Voraxaze.
More Information
Search NCI's Dictionary of Cancer Terms